AstraZeneca Pays $40 Million Upfront in AI Pact With insitro
AstraZeneca biotechnology partnership: $40M upfront, up to ~$1.46B in milestones with insitro for MASH and heart disease. See what is guaranteed.
Tag: MASH drug development
Read More